​GenAI for Drug Discovery

​Real-World Breakthroughs in Molecule Design & Drug Optimization

​Join us for the next session of our "AI IN ACTION" series, where we spotlight real-world applications of AI that are transforming industries — this time focusing on breakthroughs in pharmaceutical research and drug discovery.

​In this session, we explore how Generative AI is reinventing drug discovery from identifying promising drug candidates to optimizing molecular structures and accelerating lead discovery.

​Gain expert insights from Djork Arné Clevert, Vice President and Head of Machine Learning at Pfizer, as he shares how advanced AI techniques such as deep learning, generative models, and large scale data integration are transforming drug discovery. The session will be hosted by Bertram Weiss, Vice President Health at Merantix Momentum, who will guide the conversation and contribute perspectives from the cutting edge of AI innovation in healthcare.

​What to Expect:
✅ Real-world success stories in AI-powered drug discovery
✅ Insights into molecule design, optimization, and candidate selection
✅ A look at what’s shaping the future of pharma and biotech through deep tech
✅ Opportunities to network with AI and life sciences professionals

​Agenda
17:30 – Welcome & Networking
18:00 – Expert Talks
18:45 – Q&A Session
19:00 – Open Networking & Drinks

​We look forward to an inspiring evening of knowledge-sharing and innovation!
If you have any questions about the event, feel free to contact us at: info@merantix-momentum.com